ALERTS100%to10000%GAIN

[ALERTS100%to10000%GAIN]

UCBB~~.40,,WAKE UP PEOPLE, Set up three benchmarks to create three listed platforms

Set up three benchmarks to create three listed platforms

in biological Israel platform company, is committed to become the most Israeli investment activity and ability to operate international medical investment platform, to build "China - Israel alibaba" in the field of biomedical, listed on the NASDAQ international board implementation

Chinese and foreign joint ventures established by China, supported by global advanced technology, become the leading brand in China's medical industry segment and realize access to the A-share capital market in China

With a biological parent company, it is committed to becoming China's most dynamic international medical investment platform with investment vitality and market operation capability, and it will be listed on the main board of Hong Kong

Project partner: Israel's product/technology company obtains the five core interests:

Cash equity investment:each project can receive a $0.5-2 million equity investment, and it is possible to receive a $1 million - $10 million equity investment from a Chinese joint venture

Share the benefits of China's capital markets:China's capital market is one of the world's largest capital market, is the world's highest capital market, every 4 hours a market capitalisation of over $1 billion, the birth of the unicorn enterprise, joint venture capital markets revenue opportunity is big!

Enhance global competitiveness through the development of Chinese market:the Chinese joint venture will likely gain the CFDA approval before entering the market; Through the development of the Chinese market, the global competitiveness and global valuation of overseas medical technology companies will be promoted!

Through the Chinese OEM manufacturing cost reduce global sales:giving full play to the advantages of China as a global manufacturing center at the core of the cost, the Chinese joint venture company for the global sales of overseas medical technology companies to provide OEM, could save 30% 50% the cost of production, will greatly enhance product sales profitability in the world!

Zero risk enters China's mainland medical market:China's opportunity is the global opportunity; Global opportunities are in China! Foreign technology companies have entered the world's largest medical market in China and opened the door to the treasure trove of alibaba's wealth.

http://www.c-i-bio.com/html/capital.html?menuId